title: Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials.
authors.forename: H
authors.initials: H
authors.lastname: Armendariz
authors.forename: M A Fernandez
authors.initials: MA
authors.lastname: Barbieri
authors.forename: D
authors.initials: D
authors.lastname: Freigeiro
authors.forename: F
authors.initials: F
authors.lastname: Lastiri
authors.forename: M S
authors.initials: MS
authors.lastname: Felice
authors.forename: E
authors.initials: E
authors.lastname: Dibar
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D024221:Antineoplastic Protocols / Q000592:standards*; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D012074:Remission Induction / Q000379:methods; D016019:Survival Analysis; D016896:Treatment Outcome